Harbinger Capital
www.harbert.net/capital-partnersHarbinger Capital is a multi-billion dollar hedge fund founded in 2001 and is led by its Co-Founder and Chief Investment Officer, Philip Falcone, who has over 20 years of investment experience across an array of market cycles. The Harbinger Team is disciplined and value oriented, focusing on alpha generating ideas that are uncorrelated to investment cycles. The firm combines a flexible, innovative approach to uncovering opportunity with a thorough investment process. Each investment undergoes rigorous fundamental research, extensive vetting, and seeks an identifiable catalyst for value realization. Harbinger regards risk management as a critical component of the investment process and actively manages risk at three levels: portfolio, position and operations. The firm offers several strategies which emphasize different opportunities, each based on the same time-tested fundamental investment and risk management processes.
View Older Stories View More Recent Stories
-
HC2 Holdings Provides Business Update in Response to COVID-19 Impact
-
HC2 Broadcasting Helping McAllen, Texas Communicate Critical COVID-19 Updates over its Extensive Over-the-Air Network
-
HC2 Holdings Reports Fourth Quarter and Full Year 2019 Results
-
Tredegar Reports Fourth Quarter and Full Year 2019 Results
-
HC2 HOLDINGS ISSUES STATEMENT REGARDING PERCY ROCKDALE’S PRELIMINARY CONSENT SOLICITATION FILING
-
MG Capital Launches Consent Solicitation to Overhaul the Board of Directors of HC2 Holdings
-
HC2 Holdings to Announce Fourth Quarter and Fiscal Year 2019 Financial Results
-
HC2 Holdings Completes Sale of Global Marine Group
-
Lawsuit in NY says ex-hedge fund manager Falcone reneged on loans, wrongly sold a Warhol
-
HC2 Broadcasting Announces Carriage Of Dabl – A New Lifestyle Network
-
MG Capital Nominates Full Slate of Candidates for Election to HC2’s Board of Directors
-
HC2 Holdings Announces Appointment of Julie Springer, TransUnion Chief Marketing and Communications Officer, to its Board of Directors
-
HC2 Holdings (HCHC) in Advanced Discussions to Sell Continental Insurance, Retains Advisor to Explore Strategic Options on DBM Global
-
HC2 Holdings in Advanced Discussions to Sell Continental Insurance, Retains Advisor to Explore Strategic Options on DBM Global
-
HC2 Holdings (HCHC) to Sell Global Marine Group, Excluding the HMN Joint Venture, for $250 Million
-
HC2 Holdings Announces Definitive Agreement to Sell Global Marine Group, Excluding the HMN Joint Venture, for $250 Million
-
HC2 Holdings Reports Third Quarter 2019 Results
-
HC2's Marine Services Segment Announces Sale of Huawei Marine Networks Joint Venture
-
HC2 Broadcasting Completes $79 Million Financing
-
HC2 Holdings to Announce Third Quarter 2019 Financial Results
-
HC2 Holdings Reports Second Quarter 2019 Results
-
Pansend Life Sciences’ Portfolio Company MediBeacon Announces $30 Million Investment from Huadong Medicine and Exclusive Commercialization Partnership in Greater China
-
HC2 Holdings to Announce Second Quarter 2019 Financial Results
-
Wall Street takes on long-term care payouts as insurers balk at costs
-
Pansend Life Sciences’ Portfolio Company, R2 Dermatology, Enters Into Exclusive China/Asia-Pacific Distribution Agreement
-
HC2 Holdings Reports First Quarter 2019 Results
-
HC2 Holdings to Announce First Quarter 2019 Financial Results
-
Tredegar Reports Fourth Quarter and Full Year 2018 Results
-
HC2 Holdings Reports Fourth Quarter and Full Year 2018 Results
-
HC2 Holdings to Announce Fourth Quarter and Fiscal Year 2018 Financial Results
-
Fred's (FRED) Names Joseph Anto as CEO
-
Fred's, Inc. Announces Appointment of Chief Executive Officer and Other Key Leadership Changes
-
HC2 Portfolio Company DBM Global Inc. Completes Acquisition of GrayWolf Industrial
-
Tredegar Reports Third-Quarter 2018 Results
-
HC2 Holdings Reports Third Quarter 2018 Results
-
HC2 Holdings Sets Third Quarter 2018 Earnings Release Date And Webcast
-
HC2 Holdings (HCHC) to Explore Strategic Alternatives for Global Marine Subsidiary
-
HC2 to Explore Strategic Alternatives for Global Marine Subsidiary
-
MediBeacon Inc. Granted FDA Breakthrough Device Designation for Transdermal GFR Measurement System
-
HC2 Portfolio Company MediBeacon™ Granted Breakthrough Device Status From FDA for Transdermal GFR Measurement System
-
FDA Grants Breakthrough Device Status for MediBeacon's Transdermal GFR Measurement System
-
HC2 Portfolio Company DBM Global Inc. To Acquire GrayWolf Industrial, A Leading Provider Of Specialty Maintenance, Repair And Installation Services
-
HC2 Broadcasting Launches Network Partnership With The Christian Broadcasting Network
-
Harbinger hedge fund manager to pay $30 million in New York tax accord
-
Parent Company of HC2 Telecom Subsidiary PTGi-ICS Changes Name to ICS Group Holdings Inc.

